Fiji vs Sao Tome and Principe: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Sao Tome and Principe
100.0%
in 2024
Fiji rank
1st
Sao Tome and Principe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Sao Tome and Principe
How they compare
Fiji currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2011 it was Sao Tome and Principe ahead.
Fiji ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.8% | 27.7% | 22.1% | Fiji |
| 2020s | 81.8% | 60.0% | 21.8% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Sao Tome and Principe?
- Fiji, at 100.0% against 100.0% in Sao Tome and Principe as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Sao Tome and Principe?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Sao Tome and Principe?
- 14 years are reported by both, from 2011 to 2024.
- How do Fiji and Sao Tome and Principe rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.